Bioinnovo, the public-private company established by a partnership between Vetanco and INTA laboratories, was granted the InnovarAward by the Argentinian Ministry of Science and Technology for Bioinnovo IgY DNT, the first biological product based on IgY technology, and licensed for the prevention of Neonatal Calf Diarrhea….
We share with you the interview with Dr Andrés Wigdorovitz, Head of INCUINTA, CICVyA and INTA, Head Researcher of CONICET, and Scientific Director of Bioinnovo, on La Nación+ TV channel. FIRST PART SECOND PART
Bioinnovo received the Balseiro Award 2017 in the category “Initiatives with applications in the production of goods and/or services” in a ceremony held in the Blue Room of the Argentinian Senate. The Science and Technology for Production Forum (FOROCyTP) gave the award to Dr Amadeo…
The Science and Technology show of Chacra TV (TV channel) visited the Bioinnovo Plant at INTA Castelar, where Agustín Milic interviewed Dr Andrés Wigdorovitz, Head of INCUINTA, CICVyA and INTA, Head Researcher of CONICET, and Scientific Director of Bioinnovo. Click here to watch the interview.
Gathered in the Fair Ground of La Rural, in the capital city of Argentina, the jury of the 11th edition of the International Center for Innovation in Agricultural Technology (CiTA) Awards granted Bioinnovo the award in the Non-Traditional Innovation category, and also the Golden award,…
Bioinnovo launched a new treatment for neonatal calf diarrhea BIOINNOVO presented BIOINNOVO IgY DNT, a true innovation for the control of calf scours, a condition that causes the death of 20% of the affected animals, at Arturo E. Ragonese Botanical Garden, INTA Castelar. It is…
Official presentation of Bioinnovo IgY DNT On May 26, the Arturo E. Ragonese Botanical Gardens of INTA Castelar will hold the official launch ceremony and technical seminar on Bioinnovo IgY DNT, the first product of the first public-private company, a partnership between INTA and Vetanco….
Bioinnovo IgY DNT is approved by SENASA’s potency and biological control tests Bioinnovo IGY DNT, a new biological product available on the market, contains IgY anti-Bovine Rotavirus Elisa ≥ 2048, IgY anti-Bovine Coronavirus ≥ 64; IgY anti-Salmonella ≥ 64; IgY anti-Escherichia coli ≥ 64. Bioinnovo…
VEDEVAX. First recombinant vaccine against BVD Bioinnovo developed and licensed in Argentina the first recombinant vaccine for the control of bovine viral diarrhea. Vedevax, a subunit vaccine produced using a baculovirus line and potentiated by a targeting protein, generates highly protective antibody titers in cattle…
Bioinnovo’s first exports After a preliminary shipment for testing and promotion purposes in 2016, the first 360 kg of a Bioinnovo product was dispatched to Uruguay on March 29, 2017, for sales. Bioinnovo Terneros, the first product developed jointly by Vetanco and INTA, involved many…